Low levels of IFNs upregulate only the U-ISGF3-dependent subset of ISGs in DNA damage-resistant cancer cells, with no sustained increase in the expression of the ISGs that mediate the acute apoptotic, anti-proliferative, and inflammatory responses to IFN. The gene discussed is STAT2; the disease is cancer.